Literature DB >> 29023899

Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.

Aldo J Montano-Loza1, Vera C Mazurak2, Maryam Ebadi2, Judith Meza-Junco3, Michael B Sawyer3, Vickie E Baracos3, Norman Kneteman4.   

Abstract

Visceral adipose tissue (VAT) is a metabolically active organ, associated with higher risk of malignancies. We evaluated whether VAT is associated with the risk of hepatocellular carcinoma (HCC) in patients presenting with cirrhosis as well as HCC recurrence after liver transplantation (LT). Patients with cirrhosis (n = 678; 457 male) who were assessed for LT (289 with HCC) were evaluated for body composition analysis. Patients who underwent LT (n = 247, 168 male) were subsequently evaluated for body composition, and 96 of these patients (78 male) had HCC. VAT, subcutaneous adipose tissues, and total adipose tissues were quantified by computed tomography at the level of the third lumbar vertebra and reported as indexes (cross-sectional area normalized for height [square centimeters per square meter]). At the time of LT assessment, the VAT index (VATI) was higher in male patients with HCC compared to non-HCC patients (75 ± 3 versus 60 ± 3 cm2 /m2 , P = 0.001). The VATI, subcutaneous adipose tissue index, and total adipose tissue index were higher in male patients with HCC compared to non-HCC patients. By multivariate analysis, male patients with VATI ≥65 cm2 /m2 had a higher risk of HCC (hazard ratio, 1.90; 95% confidence interval, 1.31-2.76; P = 0.001). In male patients with HCC who underwent LT, a VATI ≥65 cm2 /m2 adjusted for Milan criteria was independently associated with higher risk of HCC recurrence (hazard ratio, 5.34; 95% confidence interval, 1.19-23.97; P = 0.03).
CONCLUSION: High VATI is an independent risk factor for HCC in male patients with cirrhosis and for recurrence of HCC after LT. (Hepatology 2018;67:914-923).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29023899     DOI: 10.1002/hep.29578

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Automated body composition analysis of clinically acquired computed tomography scans using neural networks.

Authors:  Michael T Paris; Puneeta Tandon; Daren K Heyland; Helena Furberg; Tahira Premji; Gavin Low; Marina Mourtzakis
Journal:  Clin Nutr       Date:  2020-01-22       Impact factor: 7.324

2.  High visceral adipose tissue area is independently associated with early allograft dysfunction in liver transplantation recipients: a propensity score analysis.

Authors:  Guanjie Yuan; Shichao Li; Ping Liang; Gen Chen; Yan Luo; Yaqi Shen; Xuemei Hu; Daoyu Hu; Jiali Li; Zhen Li
Journal:  Insights Imaging       Date:  2022-10-11

3.  The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Stefania Gioia; Lorenzo Ridola; Ludovica Cristofaro; Manuela Merli; Jessica Faccioli; Oliviero Riggio; Silvia Nardelli
Journal:  Liver Int       Date:  2021-09-28       Impact factor: 8.754

4.  Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma.

Authors:  Kelley Weinfurtner; Jennifer L Dodge; Francis Y K Yao; Neil Mehta
Journal:  Transplant Direct       Date:  2020-09-17

5.  Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation.

Authors:  Karolina Grąt; Ryszard Pacho; Michał Grąt; Marek Krawczyk; Krzysztof Zieniewicz; Olgierd Rowiński
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

6.  Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy.

Authors:  Maryam Ebadi; Carlos Moctezuma-Velazquez; Judith Meza-Junco; Vickie E Baracos; Abha R DunichandHoedl; Sunita Ghosh; Philippe Sarlieve; Richard J Owen; Norman Kneteman; Aldo J Montano-Loza
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

7.  Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.

Authors:  Elliot B Tapper; Peng Zhang; Rohan Garg; Tori Nault; Kate Leary; Venkat Krishnamurthy; Grace L Su
Journal:  JHEP Rep       Date:  2019-12-05

Review 8.  Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2021-02-15       Impact factor: 5.923

9.  Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.

Authors:  Nghiem B Ha; Soo-Jin Cho; Yara Mohamad; Dorothea Kent; Grace Jun; Randi Wong; Vivek Swarnakar; Shezhang Lin; Jacquelyn J Maher; Jennifer C Lai
Journal:  Dig Dis Sci       Date:  2021-06-16       Impact factor: 3.487

10.  Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.

Authors:  Chaozhi Tang; Jiakang Ma; Xiuli Liu; Zhengchun Liu
Journal:  PeerJ       Date:  2020-09-01       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.